Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2017
QoL is a cool tool
L Procaccio, S Lonardi, F Loupakis, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
June 28, 2012
Selecting the best targeted agent in first-line treatment of unresectable liver metastases from colorectal cancer: does the bench have the answers?
L Benhaim, F Loupakis, M J Labonte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 8, 2016
Challenging chemoresistant metastatic colorectal cancer: therapeutic strategies from the clinic and from the laboratory
A Sartore-Bianchi, F Loupakis, G Argilés, et al.
British Journal of Cancer
|
July 9, 2009
Do we need biopsies of metastases for colorectal cancer patients?
I Floriani, D Santini, V Torri, et al.
British Journal of Cancer
|
October 26, 2013
Reply: Comment on 'Histopathologic evaluation of liver metastases from colorectal cancer patients treated with FOLFOXIRI plus bevacizumab'
M Schirripa, F Loupakis, L Pollina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 6, 2009
Capecitabine after gastrectomy for advanced gastric cancer: have we got the patient right?
L Fornaro, E Vasile, G Masi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2015
Phase II study of single-agent cetuximab in KRAS G13D mutant metastatic colorectal cancer
M Schirripa, F Loupakis, S Lonardi, et al.
Frontiers in Nutrition
|
April 13, 2026
Novel nutraceutical combination restores hepatic deiodinase expression and protein levels under inflammatory conditions: evidence from an <i>in vitro</i> model
E Valeri, F Loupakis, G Pasqualetti, et al.
Oncology
|
March 2, 2011
Immunological effects of bevacizumab-based treatment in metastatic colorectal cancer
M Manzoni, B Rovati, M Ronzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2010
Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients
M Ronzoni, M Manzoni, S Mariucci, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2017
QoL is a cool tool
L Procaccio, S Lonardi, F Loupakis, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
June 28, 2012
Selecting the best targeted agent in first-line treatment of unresectable liver metastases from colorectal cancer: does the bench have the answers?
L Benhaim, F Loupakis, M J Labonte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 8, 2016
Challenging chemoresistant metastatic colorectal cancer: therapeutic strategies from the clinic and from the laboratory
A Sartore-Bianchi, F Loupakis, G Argilés, et al.
British Journal of Cancer
|
July 9, 2009
Do we need biopsies of metastases for colorectal cancer patients?
I Floriani, D Santini, V Torri, et al.
British Journal of Cancer
|
October 26, 2013
Reply: Comment on 'Histopathologic evaluation of liver metastases from colorectal cancer patients treated with FOLFOXIRI plus bevacizumab'
M Schirripa, F Loupakis, L Pollina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 6, 2009
Capecitabine after gastrectomy for advanced gastric cancer: have we got the patient right?
L Fornaro, E Vasile, G Masi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2015
Phase II study of single-agent cetuximab in KRAS G13D mutant metastatic colorectal cancer
M Schirripa, F Loupakis, S Lonardi, et al.
Frontiers in Nutrition
|
April 13, 2026
Novel nutraceutical combination restores hepatic deiodinase expression and protein levels under inflammatory conditions: evidence from an <i>in vitro</i> model
E Valeri, F Loupakis, G Pasqualetti, et al.
Oncology
|
March 2, 2011
Immunological effects of bevacizumab-based treatment in metastatic colorectal cancer
M Manzoni, B Rovati, M Ronzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2010
Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients
M Ronzoni, M Manzoni, S Mariucci, et al.
Page
of 6